Jay Olson
Stock Analyst at Oppenheimer
(4.84)
# 403
Out of 4,417 analysts
1161
Total ratings
48.2%
Success rate
21.8%
Average return
Main Sectors:
Stocks Rated by Jay Olson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APRE Aprea Therapeutics | Initiated Coverage: Buy | $5 | $0.7798 | +541.19% | 1 | Jun 15, 2026 | |
| ZNTL Zentalis Pharmaceuticals | Initiated Coverage: Buy | $9 | $3.62 | +148.62% | 1 | Jun 15, 2026 | |
| INCY Incyte | Maintained: Hold | $90 → $107 | $98.99 | +8.09% | 82 | Jun 8, 2026 | |
| PRAX Praxis Precision Medicines | Rated: Buy | $750 → $650 | $270.01 | +140.73% | 6 | Jun 2, 2026 | |
| RVMD Revolution Medicines | Rated: Buy | $165 → $195 | $157.77 | +23.60% | 24 | Jun 1, 2026 | |
| ANL Adlai Nortye | Initiated Coverage: Buy | $32 | $10.26 | +211.89% | 1 | May 28, 2026 | |
| CHRS Coherus Oncology | Maintained: Buy | $10 | $1.38 | +624.64% | 4 | May 12, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | $35 → $40 | $23.49 | +70.29% | 17 | May 11, 2026 | |
| NKTR Nektar Therapeutics | Maintained: Buy | $115 → $140 | $60.92 | +129.81% | 25 | May 8, 2026 | |
| NBIX Neurocrine Biosciences | Rated: Buy | $192 → $230 | $159.00 | +44.65% | 89 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 | $458.99 | +30.72% | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $33 | $6.53 | +405.36% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $52.44 | - | 35 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $92.22 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.30 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $11.94 | +67.50% | 3 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $40 | $24.43 | +63.73% | 5 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 → $72 | $33.77 | +113.21% | 2 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $61.80 | - | 5 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $4.07 | +293.12% | 4 | Apr 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $2.58 | +287.97% | 5 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $250 → $275 | $198.67 | +38.42% | 98 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $36 | $4.03 | +794.41% | 31 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $12.81 | +56.13% | 8 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.7195 | +1,289.85% | 14 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $4.41 | +580.27% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $19.99 | +200.15% | 1 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $650 | $499.86 | +30.04% | 50 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $380 → $400 | $341.66 | +17.08% | 83 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.60 | +275.00% | 4 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $2.42 | +189.26% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $39.87 | +0.33% | 3 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $27 | $15.20 | +77.63% | 26 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $74.31 | +21.11% | 14 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $30.29 | +230.14% | 38 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.78 | +349.44% | 5 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $3.62 | +397.24% | 20 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.49 | n/a | 67 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $0.4714 | n/a | 18 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $28.41 | n/a | 6 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $125.45 | n/a | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $12.54 | n/a | 35 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 | $21.60 | n/a | 36 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $53.09 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.55 | n/a | 19 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.42 | n/a | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $10 | $21.42 | n/a | 6 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $1.11 | n/a | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.78 | n/a | 10 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.05 | n/a | 16 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $6.58 | n/a | 9 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.57 | n/a | 10 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.25 | n/a | 6 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 8 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $9 | $2.27 | n/a | 45 | Aug 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $7 | $14.20 | n/a | 27 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.50 | n/a | 20 | Jul 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.11 | n/a | 19 | Mar 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.69 | n/a | 6 | Mar 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.07 | n/a | 9 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.36 | n/a | 8 | Jan 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.20 | n/a | 5 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2 → $0.25 | $3.92 | n/a | 5 | Mar 30, 2016 |
Aprea Therapeutics
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $0.7798
Upside: +541.19%
Zentalis Pharmaceuticals
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $3.62
Upside: +148.62%
Incyte
Jun 8, 2026
Maintained: Hold
Price Target: $90 → $107
Current: $98.99
Upside: +8.09%
Praxis Precision Medicines
Jun 2, 2026
Rated: Buy
Price Target: $750 → $650
Current: $270.01
Upside: +140.73%
Revolution Medicines
Jun 1, 2026
Rated: Buy
Price Target: $165 → $195
Current: $157.77
Upside: +23.60%
Adlai Nortye
May 28, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $10.26
Upside: +211.89%
Coherus Oncology
May 12, 2026
Maintained: Buy
Price Target: $10
Current: $1.38
Upside: +624.64%
Denali Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $23.49
Upside: +70.29%
Nektar Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $115 → $140
Current: $60.92
Upside: +129.81%
Neurocrine Biosciences
May 6, 2026
Rated: Buy
Price Target: $192 → $230
Current: $159.00
Upside: +44.65%
May 5, 2026
Maintained: Buy
Price Target: $600
Current: $458.99
Upside: +30.72%
May 1, 2026
Rated: Buy
Price Target: $25 → $33
Current: $6.53
Upside: +405.36%
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $52.44
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $92.22
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $5.30
Upside: -
Apr 24, 2026
Maintained: Buy
Price Target: $20
Current: $11.94
Upside: +67.50%
Apr 23, 2026
Maintained: Buy
Price Target: $25 → $40
Current: $24.43
Upside: +63.73%
Apr 22, 2026
Maintained: Buy
Price Target: $61 → $72
Current: $33.77
Upside: +113.21%
Apr 20, 2026
Rated: Hold
Price Target: n/a
Current: $61.80
Upside: -
Apr 5, 2026
Rated: Buy
Price Target: $16
Current: $4.07
Upside: +293.12%
Apr 2, 2026
Rated: Buy
Price Target: $10
Current: $2.58
Upside: +287.97%
Apr 1, 2026
Rated: Buy
Price Target: $250 → $275
Current: $198.67
Upside: +38.42%
Mar 18, 2026
Maintained: Buy
Price Target: $44 → $36
Current: $4.03
Upside: +794.41%
Mar 11, 2026
Maintained: Buy
Price Target: $20
Current: $12.81
Upside: +56.13%
Mar 11, 2026
Maintained: Buy
Price Target: $10
Current: $0.7195
Upside: +1,289.85%
Mar 9, 2026
Reiterated: Buy
Price Target: $30
Current: $4.41
Upside: +580.27%
Feb 25, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $19.99
Upside: +200.15%
Feb 9, 2026
Maintained: Buy
Price Target: $650
Current: $499.86
Upside: +30.04%
Jan 29, 2026
Maintained: Buy
Price Target: $380 → $400
Current: $341.66
Upside: +17.08%
Nov 13, 2025
Maintained: Buy
Price Target: $6
Current: $1.60
Upside: +275.00%
Nov 13, 2025
Maintained: Buy
Price Target: $7
Current: $2.42
Upside: +189.26%
Nov 13, 2025
Maintained: Buy
Price Target: $40
Current: $39.87
Upside: +0.33%
Nov 7, 2025
Maintained: Buy
Price Target: $40 → $27
Current: $15.20
Upside: +77.63%
Oct 27, 2025
Maintained: Buy
Price Target: $90
Current: $74.31
Upside: +21.11%
Oct 7, 2025
Maintained: Buy
Price Target: $100
Current: $30.29
Upside: +230.14%
Oct 7, 2025
Maintained: Buy
Price Target: $8
Current: $1.78
Upside: +349.44%
Oct 2, 2025
Maintained: Buy
Price Target: $18
Current: $3.62
Upside: +397.24%
Jun 16, 2025
Maintained: Hold
Price Target: n/a
Current: $8.49
Upside: n/a
Jun 16, 2025
Maintained: Buy
Price Target: $65
Current: $0.4714
Upside: n/a
Mar 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $28.41
Upside: n/a
Feb 12, 2025
Reiterated: Buy
Price Target: $115
Current: $125.45
Upside: n/a
Dec 10, 2024
Maintained: Hold
Price Target: $14
Current: $12.54
Upside: n/a
Nov 8, 2024
Maintained: Hold
Price Target: $17
Current: $21.60
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $95
Current: $53.09
Upside: n/a
Nov 5, 2024
Reiterated: Hold
Price Target: n/a
Current: $2.55
Upside: n/a
Nov 4, 2024
Maintained: Buy
Price Target: $9
Current: $1.42
Upside: n/a
Oct 17, 2024
Maintained: Buy
Price Target: $9 → $10
Current: $21.42
Upside: n/a
Aug 12, 2024
Maintained: Buy
Price Target: $33
Current: $1.11
Upside: n/a
Feb 26, 2024
Rated: Hold
Price Target: n/a
Current: $1.78
Upside: n/a
Feb 14, 2023
Downgraded: Hold
Price Target: n/a
Current: $11.05
Upside: n/a
Nov 14, 2022
Upgraded: Buy
Price Target: $7
Current: $6.58
Upside: n/a
Aug 14, 2020
Rated: Hold
Price Target: n/a
Current: $9.57
Upside: n/a
Jun 12, 2020
Rated: Hold
Price Target: n/a
Current: $1.25
Upside: n/a
May 8, 2020
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 22, 2019
Maintained: Buy
Price Target: $10 → $9
Current: $2.27
Upside: n/a
Aug 14, 2019
Maintained: Buy
Price Target: $15 → $7
Current: $14.20
Upside: n/a
Jul 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $4.50
Upside: n/a
Mar 24, 2019
Maintained: Buy
Price Target: n/a
Current: $2.11
Upside: n/a
Mar 15, 2019
Rated: Hold
Price Target: n/a
Current: $0.69
Upside: n/a
Dec 8, 2017
Rated: Hold
Price Target: n/a
Current: $4.07
Upside: n/a
Jan 20, 2017
Rated: Hold
Price Target: n/a
Current: $7.36
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: n/a
Current: $12.20
Upside: n/a
Mar 30, 2016
Maintained: Sell
Price Target: $2 → $0.25
Current: $3.92
Upside: n/a